Heavy metal and trace element alterations in patients during a migraine attack
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Sevilay Vural, Vugar Ali Türksoy, Aytül Uzun Akgeyik, Mikail Kuşdoğan |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
par: Stephen Silberstein, et autres
Publié: (2026)
par: Stephen Silberstein, et autres
Publié: (2026)
Preserved working memory performance along with subcortical modulation during peri‐ictal phases in spontaneous migraine attacks
par: Amparo Ruiz‐Tagle, et autres
Publié: (2024)
par: Amparo Ruiz‐Tagle, et autres
Publié: (2024)
Migraine is a disorder of function: No evidence for structural alterations within the central nervous system in migraine
par: Jan Mehnert, et autres
Publié: (2025)
par: Jan Mehnert, et autres
Publié: (2025)
Useful considerations for treating migraine in patients with autism
par: Sinifunanya E. Nwaobi
Publié: (2026)
par: Sinifunanya E. Nwaobi
Publié: (2026)
Cardiovascular risk and triptan usage among patients with migraine
par: Ido Peles, et autres
Publié: (2025)
par: Ido Peles, et autres
Publié: (2025)
Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double‐blind, randomized, controlled trial ( PAREMA1 )
par: Charly Gaul, et autres
Publié: (2025)
par: Charly Gaul, et autres
Publié: (2025)
Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
par: Antonio Munafò, et autres
Publié: (2026)
par: Antonio Munafò, et autres
Publié: (2026)
Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
par: Chia‐Chun Chiang, et autres
Publié: (2024)
par: Chia‐Chun Chiang, et autres
Publié: (2024)
Comparative bioavailability of single‐dose zavegepant during and between migraine attacks: A phase 1, randomized, open‐label, fixed‐sequence, two‐period study
par: Richard J. Bertz, et autres
Publié: (2024)
par: Richard J. Bertz, et autres
Publié: (2024)
Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
par: Richard B. Lipton, et autres
Publié: (2025)
par: Richard B. Lipton, et autres
Publié: (2025)
Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
par: Graham A. McLeod, et autres
Publié: (2025)
par: Graham A. McLeod, et autres
Publié: (2025)
Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
par: Lawrence C. Newman, et autres
Publié: (2025)
par: Lawrence C. Newman, et autres
Publié: (2025)
Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study
par: Seonyoung Kang, et autres
Publié: (2024)
par: Seonyoung Kang, et autres
Publié: (2024)
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
par: Andrew Blumenfeld, et autres
Publié: (2024)
par: Andrew Blumenfeld, et autres
Publié: (2024)
Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
par: Jessica Ailani, et autres
Publié: (2026)
par: Jessica Ailani, et autres
Publié: (2026)
Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation
par: Vishwesh Vishnu Naik, et autres
Publié: (2025)
par: Vishwesh Vishnu Naik, et autres
Publié: (2025)
Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine
par: Yukihisa Suzuki, et autres
Publié: (2024)
par: Yukihisa Suzuki, et autres
Publié: (2024)
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
par: Rikki Mangrum, et autres
Publié: (2024)
par: Rikki Mangrum, et autres
Publié: (2024)
The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
par: Yunus Emre Meydanal, et autres
Publié: (2025)
par: Yunus Emre Meydanal, et autres
Publié: (2025)
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
par: Muneto Tatsumoto, et autres
Publié: (2024)
par: Muneto Tatsumoto, et autres
Publié: (2024)
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine
par: Ye Su, et autres
Publié: (2024)
par: Ye Su, et autres
Publié: (2024)
Do patients with migraine and obesity receive different treatments? Insights from real‐world data
par: Keshet Pardo, et autres
Publié: (2025)
par: Keshet Pardo, et autres
Publié: (2025)
Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
par: Gabriel Camargo de Oliveira, et autres
Publié: (2026)
par: Gabriel Camargo de Oliveira, et autres
Publié: (2026)
No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
par: Inga Zalia Tummoszeit, et autres
Publié: (2024)
par: Inga Zalia Tummoszeit, et autres
Publié: (2024)
Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
par: Christoph T. Berger, et autres
Publié: (2026)
par: Christoph T. Berger, et autres
Publié: (2026)
Evaluating associations of migraine‐related vertigo
par: Nazia Karsan, et autres
Publié: (2025)
par: Nazia Karsan, et autres
Publié: (2025)
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study
par: E. S. Hoogeveen, et autres
Publié: (2024)
par: E. S. Hoogeveen, et autres
Publié: (2024)
Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
par: Julia Peris‐Subiza, et autres
Publié: (2025)
par: Julia Peris‐Subiza, et autres
Publié: (2025)
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
par: Anna de Dios, et autres
Publié: (2024)
par: Anna de Dios, et autres
Publié: (2024)
Rising migraine incidence in adolescents despite stable prevalence in the US : A call for further investigation
par: Ali Reza Tavasoli, et autres
Publié: (2024)
par: Ali Reza Tavasoli, et autres
Publié: (2024)
Letter to the Editor regarding “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”
par: Hinpetch Daungsupawong, et autres
Publié: (2025)
par: Hinpetch Daungsupawong, et autres
Publié: (2025)
Early effect of onabotulinumtoxinA on EEG ‐based functional connectivity in patients with chronic migraine: A pilot study
par: Matteo Conti, et autres
Publié: (2024)
par: Matteo Conti, et autres
Publié: (2024)
Evaluation of the effectiveness and safety of anti‐CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO ‐ CGRP study
par: María Clara García‐Castillo, et autres
Publié: (2026)
par: María Clara García‐Castillo, et autres
Publié: (2026)
No differences in subcortical volume between people with and without migraine: A REFORM study
par: Basit Ali Chaudhry, et autres
Publié: (2025)
par: Basit Ali Chaudhry, et autres
Publié: (2025)
Afterimage duration differs for migraine with or without aura
par: Florian Rimmele, et autres
Publié: (2025)
par: Florian Rimmele, et autres
Publié: (2025)
Mechanisms for mindfulness in migraine: Does catastrophizing matter?
par: Rebecca Erwin Wells, et autres
Publié: (2024)
par: Rebecca Erwin Wells, et autres
Publié: (2024)
Reassessing pediatric migraine disability: Toward an updated assessment tool in the era of novel therapeutics
par: Ali Reza Tavasoli, et autres
Publié: (2025)
par: Ali Reza Tavasoli, et autres
Publié: (2025)
Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
par: Shuu‐Jiun Wang, et autres
Publié: (2024)
par: Shuu‐Jiun Wang, et autres
Publié: (2024)
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis
par: Scott W. Kirkland, et autres
Publié: (2024)
par: Scott W. Kirkland, et autres
Publié: (2024)
Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program
par: Idris Demirsoy, et autres
Publié: (2025)
par: Idris Demirsoy, et autres
Publié: (2025)
Documents similaires
-
Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
par: Stephen Silberstein, et autres
Publié: (2026) -
Preserved working memory performance along with subcortical modulation during peri‐ictal phases in spontaneous migraine attacks
par: Amparo Ruiz‐Tagle, et autres
Publié: (2024) -
Migraine is a disorder of function: No evidence for structural alterations within the central nervous system in migraine
par: Jan Mehnert, et autres
Publié: (2025) -
Useful considerations for treating migraine in patients with autism
par: Sinifunanya E. Nwaobi
Publié: (2026) -
Cardiovascular risk and triptan usage among patients with migraine
par: Ido Peles, et autres
Publié: (2025)